Volker Ehemann
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 9
- Cancer Genomics and Diagnostics 5
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research 11
- RNA Interference and Gene Delivery 9
- DNA Repair Mechanisms 6
- Oncology top 5%
- Cancer-related Molecular Pathways 15
- Cell Biology top 5%
- Microtubule and mitosis dynamics 10
- Neurology top 5%
- Neuroblastoma Research and Treatments 17
- Co-authors
- Manfred SchwabPeter SchirmacherSabine ZitzmannFrank WestermannJürgen KopitzMichael CantzThomas LongerichMatthias Fischer
- Journals
- Cancer Letters (7 papers)Hepatology (6 papers)International Journal of Medical Sciences (4 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Volker Ehemann
96 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 118
- Cancer Research 798
- Molecular Biology 2.3k
- Oncology 889
- Cell Biology 452
- Neurology 413
Countries citing papers authored by Volker Ehemann
This map shows the geographic impact of Volker Ehemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volker Ehemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volker Ehemann more than expected).
Fields of papers citing papers by Volker Ehemann
This network shows the impact of papers produced by Volker Ehemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volker Ehemann. The network helps show where Volker Ehemann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Volker Ehemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 27 | |
| 2 | 2013 | 52 | |
| 3 | 2013 | 159 | |
| 4 | 2012 | 24 | |
| 5 | 2011 | 64 | |
| 6 | 2010 | 43 | |
| 7 | 2009 | 83 | |
| 8 | Treatment of glioblastoma multiforme cells with temozolomide-BioShuttle ligated by the inverse Diels-Alder ligation chemistry | 2009 | 6 |
| 9 | 2009 | 101 | |
| 10 | 2009 | 129 | |
| 11 | 2008 | 35 | |
| 12 | 2007 | 39 | |
| 13 | 2007 | 51 | |
| 14 | 2007 | 38 | |
| 15 | 2007 | 17 | |
| 16 | 2005 | 34 | |
| 17 | 2004 | 4 | |
| 18 | 2003 | 53 | |
| 19 | 1999 | 33 | |
| 20 | Effects of cell surface ganglioside sialidase inhibition on growth control and differentiation of human neuroblastoma cells. | 1997 | 67 |
About Volker Ehemann
Volker Ehemann is a scholar working on Neurology, Cancer Research and Oncology, having authored 96 papers that have together received 3.5k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (17 papers), Cancer-related Molecular Pathways (15 papers), Histone Deacetylase Inhibitors Research (11 papers), Microtubule and mitosis dynamics (10 papers), RNA Interference and Gene Delivery (9 papers), Cancer, Hypoxia, and Metabolism (9 papers), DNA Repair Mechanisms (6 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Cancer Research (798 citations), Molecular Biology (2.3k citations) and Oncology (889 citations). Volker Ehemann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Manfred Schwab, Peter Schirmacher, Sabine Zitzmann, Frank Westermann, Jürgen Kopitz, Michael Cantz, Thomas Longerich, Matthias Fischer, Kai Breuhahn and Jürgen Debus. Their work appears in journals such as Cancer Letters, Hepatology, International Journal of Medical Sciences, International Journal of Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.